Stay updated with breaking news from Wize Pharma Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The first Israeli biotech company, where he served as Director of R&D from 1980 to 1987. During his managerial career Dr. Havron was directly involved in the multi-disciplinary development of many... | June 8, 2023
Vertua Limited (NSX:VER) purses unique investment opportunities.
Research Analysts’ downgrades for Tuesday, May 24th: Antero Resources (NYSE:AR) was downgraded by analysts at Zacks Investment Research from a strong-buy rating to a hold rating. The firm currently has $42.00 price target on the stock. According to Zacks, “Antero Resources has positioned itself among the fast-growing natural gas producers in the United States. The […]
Mawson Infrastructure Group (NASDAQ:MIGI – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued on Tuesday, Zacks.com reports. According to Zacks, “Mawson Infrastructure Group Inc. is a digital infrastructure provider, with diversified operations across Cryptocurrency Mining and Digital Asset Management. It operates principally […]
Wize Pharma's Takeover Offer for Cosmos Capital Declared Unconditional USA - English News provided by Share this article Share this article HOD HASHARON, Israel, Feb. 16, 2021 /PRNewswire/ -- Wize Pharma, Inc. (OTCQB: WIZP), a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, today announced that it has declared its previously announced off-market takeover offer ("Offer") for all of the ordinary shares in Cosmos Capital Limited, a leading digital infrastructure provider based in Sydney, Australia ("Cosmos"), free from all of the conditions set out in t...